Skip to main content

Tag: pets

Is Medical Cannabis For Animals The Next Big Thing?

When most people think of medical cannabis, they think of how it pertains to suffering human patients, and rightfully so. Medical cannabis has helped countless human patients as a growing body of scientific research and patient testimonials demonstrates.

However, the benefits of medical cannabis are not limited only to humans. Many household pets and livestock can also benefit from the wellness properties contained within the cannabis plant and medical products derived from it.

More governments around the world are recognizing this fact and modernizing their cannabis policies and regulations to reflect it. For example, back in late 2019 Malta’s Minister for the Economy announced plans to permit the production of medical cannabis for veterinarian use.

Late last year, Brazil’s National Health Surveillance Agency decided to amend Ordinance SVS/MS 344/1998 to allow the regulation of medical cannabis products for animals by the Ministry of Agriculture and Livestock. Other examples of similar policy modernization can be found elsewhere around the globe.

Medical cannabis for animals is an underrated sector of the emerging legal cannabis industry and possesses tremendous profit potential for innovative entrepreneurs and savvy cannabis industry investors.

Industry analysts at Research and Markets recently projected that the CBD pet market size alone is expected to reach $1.72 billion by 2030 and increase at a compound annual growth rate of 32.47% between now and then. This of course does not take into account other cannabinoids and non-pet animals like farm livestock.

Researchers estimate that there are over 900 million pet dogs globally, and another 370 million pet cats. In the United States alone pet owners spend an estimated $136 billion on pet products annually. Add to the mix tens of billions of cattle, sheep, goats, chickens, pigs, and other livestock around the world, and the potential market for medical cannabis wellness products for animals is off the charts.

The medical cannabis for animals sector is very young and has hurdles to overcome to be sure, not the least of which is the need for more research. Determining which cannabinoids and in which specific doses for each animal type and size is no small feat.

With that being said, individuals and entities who can figure it out safely and reliably are sure to reap considerable financial rewards in the future. Medical cannabis for animals is virtually guaranteed to be the next big thing. It is not a question of if, but rather, a question of when.

Brazilian Researchers Determine That CBD Is Safe For Dogs

An area of the emerging cannabis industry that is often overlooked is cannabis products for pets. Worldwide, it is estimated that over half of the households around the globe own a pet and many of those households own more than one pet.

The most popular pet type around the world is dogs, with as many as 33% of households around the planet estimated to own at least one dog. With that in mind, any product that can effectively and safely help dogs live better lives is obviously something that there would be a tremendous demand for.

Medical cannabis products for pets is still a very young sector within the emerging cannabis industry, and quite a bit of research is needed to help ensure product safety.

However, at the macro level, cannabis appears to be safe for pets, especially cannabidiol, as long as it’s administered in the right dosage level. Below is more information about it via an abstract of a recent study conducted in Brazil:

The review was systematically performed in Medline (via Pubmed®) and Latin American and Caribbean Health Sciences Literature (LILACS) databases, with period restriction (between 1990 and 2021). The qualified articles (n=19), which met the previously established inclusion criteria, were critically evaluated.

Based on the literature review, it is possible to infer safety in the administration of cannabis-based products for the treatment of dogs, especially products rich in cannabidiol (CBD), free or with low concentrations of tetrahydrocannabinol, under the conditions evaluated. In addition, CBD products potentially promote improved quality of life and reduce pain perception in animals affected by canine osteoarthritis.

Finally, owing to the lack of large-scale and robust clinical research studies, the performance of clinical trials, considering the individual characteristics of each cannabis-based product (composition, concentration, nature of adjuvants, dosage form, route of administration), is strongly encouraged.

Now, before you run out and grab the nearest cannabis product that you can find and try to give it to your dog, keep the results of this study in context.

Dogs are far more sensitive to medications than humans, and not only is it important to get the right medical cannabis product designed specifically for a dog of a specific size, it is also important to use the right dosage level and use the right consumption method.

Check with a veterinarian prior to administering medical cannabis products to your dog or any other pet that you may have.